Physicochemical Properties
| Molecular Formula | C24H22CL2N6O3 |
| Molecular Weight | 513.3759 |
| Exact Mass | 512.113 |
| CAS # | 717899-97-3 |
| Related CAS # | 941588-94-9 (mesylate);717899-97-3;941588-98-3;941588-96-1 (besylate); |
| PubChem CID | 16048643 |
| Appearance | White to off-white solid powder |
| LogP | 4.1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Heavy Atom Count | 35 |
| Complexity | 761 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | ClC1C([H])=C(C([H])=C([H])C=1N([H])C(N([H])C1=C(C([H])=C([H])C(=C1[H])C(C1=C([H])N(C2C1=C(N([H])[H])N=C([H])N=2)C([H])(C([H])([H])[H])C([H])([H])[H])=O)OC([H])([H])[H])=O)Cl |
| InChi Key | VFCRSIORGUNNGT-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C24H22Cl2N6O3/c1-12(2)32-10-15(20-22(27)28-11-29-23(20)32)21(33)13-4-7-19(35-3)18(8-13)31-24(34)30-17-6-5-14(25)9-16(17)26/h4-12H,1-3H3,(H2,27,28,29)(H2,30,31,34) |
| Chemical Name | 1-[5-(4-amino-7-propan-2-ylpyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxyphenyl]-3-(2,4-dichlorophenyl)urea |
| Synonyms | CE245677; CE 245677; CE-245677 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | CE-245677 exhibits >100-fold action against numerous additional angiogenic receptor tyrosine kinases (e.g., KDR, PDGFR, FGFR) selectivity. It is a strong and reversible inhibitor of Tie2 and TrkA/B kinases, with cellular IC50s of 4.7 and 1 nM, respectively[1]. |
| ln Vivo | CE-245677 demonstrated good oral absorption (F=80%) in a rat PK investigation conducted in vivo [1]. |
| References |
[1]. Identification of selective, orally active Tie2 kinase inhibitors and discovery of CE-245,677 and PF-371,989. Cancer Research. AACR Annual Meeting-Apr 14-18, 2007. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~125 mg/mL (~243.48 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (4.05 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (4.05 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.9479 mL | 9.7394 mL | 19.4787 mL | |
| 5 mM | 0.3896 mL | 1.9479 mL | 3.8957 mL | |
| 10 mM | 0.1948 mL | 0.9739 mL | 1.9479 mL |